Business directory profile

Adocia


adocia.com


Access Company Details

Adocia

Office phone +33 4 72 61 ** **
Get Phone Number

Homepage https://www.adocia.com
LinkedIn Profile https://linkedin.com/company/a***ci***
HQ Location France , Auvergne-Rhône-Alpes, Lyon
:115 Av. Lacassagne, 69003 Lyon, France
Coordinates 46.******° N, 5.******° E
Last Update 2023-01-30
Manage your Business
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform is designed and developed based on novel polymers, oligomers, and small molecules to enhance the effectiveness and/or safety of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations of insulin analogs; HinsBet U100, a rapid-acting formulation of human insulin; BioChaperone Combo, a combination of basal insulin glargine and rapid-acting insulin lispro; BioChaperone Pramlintide Insulin, a prandial combination of human insulin with amylin pramlintide; and BioChaperone Human Glucagon, an aqueous formulation of human glucagon. It is also developing BioChaperone Glargine Dulaglutide and BioChaperone Glargine Liraglutide that are combinations of insulin glargine with GLP-1s; BioChaperone Teduglutide, an aqueous formulation of teduglutide, a GLP-2 analog for the treatment of short bowel syndrome; and BioChaperone Glucagon GLP-1, a combination of glucagon and a GLP-1 receptor agonist for the treatment of obesity. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. Adocia SA was founded in 2005 and is headquartered in Lyon, France.



Biotechnology and Molecular Biology Research

Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.

Career Opportunities at Adocia






Details of Adocia

Stock information
A89.F FRA
Founded in
2005
Services
Appcenso redcensored censored
Dcensore
Icensor edcensoredc
Dcen soredcen
Fcen soredce
Wcens oredcen
Dcensore dcen sored
Gcenso redcens
Ccensore dcensor
Mocensored censoredce
cens
Ancensoredcen soredcens
cen
Ncensoredc
Ncensoredcen
censored
Industry
Biotechnology and Molecular Biology Research
Company Type
Private Company
Enterprise Size
censo redcens
Headquartered
France, Auvergne-Rhône-Alpes, Lyon
Website
https://www.adocia.com


Related Companies and Competitors




Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.